1Y Annualised Return
▲11.20%
3Y Annualised Return
▲39.01%
5Y Annualised Return
▲46.88%
Auro Laboratories SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹68,79,375 (+5.84%)
Daily SIP of ₹25,000 would have become ₹68,79,375 in 1 year with a gain of ₹3,79,375 (+5.84%)
Auro Laboratories Stock Performance
Today’s Low - High
251.30
259.90
251.30
259.90
52 Week Low - High
156.40
298.00
156.40
298.00
Open
259.75
Prev. Close
259.25
Volume
2,857.00
Total Traded Value
7.41 L
Auro Laboratories Fundamental
Market Cap (in crs)
161.70
Face Value
10
Turnover (in lacs)
7.41
Key Metrics
Qtr Change %
65.89% Gain from 52W Low
11.7
Dividend yield 1yr %
0
Auro Laboratories Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
259.45
Current Price
5Day EMA
257.70
10Day EMA
255.60
12Day EMA
254.90
20Day EMA
252.50
26Day EMA
251.00
50Day EMA
246.40
100Day EMA
240.30
200Day EMA
227.00
5Day SMA
257.20
10Day SMA
256.20
20Day SMA
250.40
30Day SMA
250.60
50Day SMA
245.10
100Day SMA
240.80
150Day SMA
239.20
200Day SMA
227.80
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 2740 Rs | 2857 Rs |
Week Rs | 2081 Rs | 2434 Rs |
Month Rs | 2566 Rs | 3114 Rs |
Resistance & Support
256.88
Pivot
Resistance
First Resistance
262.47
Second Resistance
265.48
Third Resistance
271.07
Support
First Support
253.87
Second support
248.28
Third Support
245.27
Relative Strength Index
58.66
Money Flow Index
50.88
MACD
3.85
MACD Signal
3.19
Average True Range
14.13
Average Directional Index
11.97
Rate of Change (21)
2.35
Rate of Change (125)
30.38
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96.95 0.03 (0.00%)▼ | 154.83 | 78.06 | 157.98 | 96.92 | -0.28% | -12.67% | -29.09% | -2.75% | -4.33% | 1.23% | 14.96 | 40.83 | 1.45 | |
74.90 +1.97 (+2.74%)▲ | 161.25 | 61 | 129.07 | 72.93 | -1.50% | -5.53% | -9.13% | 13.58% | -39.00% | 0.00% | 0.00 | 40.83 | -1.11 | |
135.80 -1.70 (1.47%)▼ | 155.44 | 103 | 182.45 | 137.50 | 13.45% | 13.64% | 15.43% | -18.24% | -28.49% | 0.00% | 43.67 | 40.83 | 2.17 | |
13.07 +0.33 (+8.00%)▲ | 140.21 | 10.3 | 24.91 | 12.74 | 2.83% | -11.50% | -20.05% | -15.56% | 65.78% | 0.00% | 327.00 | 40.83 | 2.14 | |
Quest Laboratories Ltd. | 99.00 | 99.00 | - | - | - | - | - | - | - | - | - | - | - | - |
83.99 0.01 (0.00%)▼ | 168.01 | 67.5 | 104.9 | 83.98 | -7.19% | 1.89% | 0.00% | 0.00% | 0.00% | 0.00% | 13.42 | 40.83 | 2.54 |
Auro Laboratories Company background
Founded in: 1989
Managing director: Sharat Deorah
Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the firstline treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organizationSince inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA.The Companys primary focus was on AntiDiabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for APIs and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.The Company received ISO 9001:2000 and WHO cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.
Auro Laboratories FAQs
What is the Mutual Fund shareholding in Auro Laboratories ?
The Mutual Fund Shareholding in Auro Laboratories was 0.01% at the end of 23/5/2025.
How to buy Auro Laboratories shares?
You can easily buy Auro Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Auro Laboratories stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
